Clinical Trial: Dosing of Amicar and Measure of Fibrinolysis by TEG During Cardiac Surgery
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: The Effect of Standard vs Aggressive Dosing Regimens for Epsilon-aminocaproic Acid on a Quantifiable Parameter of Fibrinolysis as Measured by Thromboelastography
Brief Summary: This study hopes to determine the optimal antifibrinolytic dosing to decrease bleeding and blood transfusion after cardiac surgery without increasing adverse events
Detailed Summary:
Sponsor: University of Pennsylvania
Current Primary Outcome: degree of fibrinolysis as measured by thromboelastography [ Time Frame: Length of cardiac surgery ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: University of Pennsylvania
Dates:
Date Received: October 16, 2013
Date Started: January 2013
Date Completion:
Last Updated: August 18, 2016
Last Verified: August 2016